PDGF (Ariessence) in Atlanta, GA
Most topical products stop at the surface. That is not a marketing failing — it is what skin is built to do, and the barrier that keeps things out is the same barrier that keeps you healthy. Topical growth-factor therapy is designed around that constraint rather than against it: it is applied when the barrier has been deliberately and temporarily opened, so the molecules have a route in. Platelet-derived growth factor is the signal in question, and the treatment it belongs to is an add-on rather than a procedure of its own.
The Benefits
A Growth-Factor Signal
It supplies platelet-derived growth factor, one of the principal signaling proteins the body itself uses to coordinate repair, rather than an inert cosmetic ingredient.
Applied, Not Injected
It is applied topically rather than injected, so it adds no needles, no injection points, and no bruising of its own to the appointment.
Built For Microneedling
It is designed around the window microneedling creates, when temporary micro-channels give a large molecule a route past a barrier that would otherwise exclude it.
Supports Recovery
Applied after a resurfacing or needling procedure, it is intended to support the recovery and remodeling the procedure has already set in motion.
No Needles Of Its Own
As an add-on it fits into an existing appointment rather than requiring a separate visit, separate downtime, or a separate recovery.
Skin Quality, Not Shape
It targets skin quality — texture, tone, and surface smoothness — which is a different category of improvement from what an injectable provides.
Gradual And Cumulative
Any effect accrues gradually across a course of treatment rather than appearing at once, which suits a maintenance-oriented plan.
Ask What Is In It
The category rewards asking specific questions — what growth factors, from what source, at what concentration — and a provider who answers those clearly is telling you something useful.
What PDGF (Ariessence) Is
Platelet-derived growth factor is a signaling protein that the body releases from platelets at a site of injury. It is one of the principal messengers in wound healing: it recruits fibroblasts and other repair cells to the site, prompts them to multiply, and drives the production of new extracellular matrix and collagen. It also supports angiogenesis, the formation of small blood vessels that supply healing tissue. It is not a moisturizer, an acid, or a retinoid — it is a message, and what it does depends entirely on whether it reaches cells that can receive it.
Topical growth-factor therapy applies preparations containing PDGF, often alongside other growth factors and supporting ingredients, directly to the skin. Ariessence is a branded topical growth-factor product used in this way. Because formulations in this category differ substantially in what they contain, how the growth factors are produced, and at what concentration, the specific product matters and is worth asking about rather than assuming.
The central practical problem is penetration. Growth factors are large proteins, and the stratum corneum — the outermost layer of skin — is extremely effective at excluding large molecules. Applied to intact, undisturbed skin, a protein of this size does not meaningfully reach the dermis where fibroblasts live. This is not a controversial point; it is basic skin physiology, and it is the reason this category of product is almost always paired with a procedure rather than sold as a stand-alone serum with dramatic claims.
That pairing is the actual treatment. Microneedling creates thousands of temporary micro-channels through the barrier. For a period afterward, those channels provide a route for a topical preparation to reach a depth it otherwise could not. Applying a growth-factor preparation during that window is the rationale for the combination, and it is why this appears in most treatment menus as an add-on to needling or as post-procedure care rather than as an appointment in its own right.
One regulatory point is worth understanding. Topical cosmetic products in the United States are not subject to pre-market FDA approval in the way drugs and many devices are. A topical growth-factor preparation is generally marketed as a cosmetic, which means it has not been reviewed for effectiveness by the FDA, and claims about what it achieves rest on the manufacturer's own testing. That does not make such products useless, and many have reasonable supporting data. It does mean the burden of asking sensible questions falls on you.
How It Works
Wound healing proceeds through overlapping phases: an initial inflammatory response, a proliferative phase in which cells multiply and new matrix is laid down, and a long remodeling phase in which that matrix is reorganized and strengthened. Growth factors are the signaling molecules that coordinate the handoffs. Platelet-derived growth factor is prominent in the early proliferative phase, where its principal roles are chemotaxis — drawing fibroblasts and immune cells to the site — and mitogenesis, prompting those cells to divide. It also stimulates fibroblasts to produce collagen and other matrix components, and contributes to the formation of new blood vessels.
Applied topically to skin whose barrier has been temporarily breached, the proposal is that these molecules reach the upper dermis and add to the signaling already generated by the procedure itself. Microneedling works precisely by creating controlled micro-injury and letting the body's own healing response remodel the tissue. Supplying additional growth-factor signal into that window is intended to reinforce a process already underway rather than to start a new one.
The penetration question is the whole basis for the pairing. The stratum corneum excludes molecules above a relatively small size threshold, and growth factors are well above it. Micro-channels created by needling remain open for a limited period — commonly described in hours rather than days — and that window is when a topical of this kind can reach a useful depth. Outside that window, applying the same product to intact skin delivers considerably less, which is why sequencing matters and why the treatment is tied to a procedure.
The same open-channel logic imposes a constraint that is not optional. Anything applied during that window reaches deeper than it would otherwise, which means only preparations intended and formulated for post-procedure use should go on the skin. This is the reason providers are specific about what you may and may not apply in the hours and days after needling, and why using your usual skincare early is a genuine problem rather than a minor deviation.
What PDGF (Ariessence) Treats
Skin quality and texture
The general target: smoother surface, more even tone, and a better-hydrated look. This is a quality change rather than a structural one, and it is gradual.
Recovery after microneedling or resurfacing
The most common use. Applied during and after a procedure that has opened the barrier, the intention is to support the repair response the procedure has already triggered.
Fine lines and early textural change
Superficial lines associated with declining dermal collagen are the plausible target. Deeper static folds and dynamic expression lines are different problems needing different treatments.
Dull, tired-looking skin
Improved surface quality and light reflection is what patients most often describe from this category of product, particularly in combination with a resurfacing or needling course.
Post-inflammatory texture and early scarring
Frequently included in plans for textural change following acne, where needling supplies the remodeling stimulus and the topical supplies additional signaling. Scar treatment is a series commitment with modest goals.
Thin or fragile skin
Skin that has lost thickness is the population a collagen-supporting approach is aimed at, though a topical adjunct is a supporting element in such a plan rather than the centerpiece.
Maintenance between in-office treatments
Some protocols include continued home use between appointments. Whether that is worthwhile depends on the specific formulation and is a fair question to ask directly.
Not volume, contour, or facial shape
Listed deliberately. Nothing about a topical growth-factor preparation addresses volume loss, structural descent, or muscle-driven lines, and no formulation changes that.
Is PDGF (Ariessence) Right For You?
You May Be A Good Candidate If
- Adults having microneedling or a resurfacing procedure who want to add a growth-factor step during the window when the skin barrier is open.
- People whose goals are skin quality, texture, and tone rather than volume, contour, or a change in facial shape.
- People with realistic expectations about what an adjunct does. This supports a procedure; it does not substitute for one, and it is not the element doing most of the work.
- People with fine lines, dullness, or early textural change who are pursuing a course of treatment rather than a single appointment.
- People with post-acne textural change who are already committed to a needling or resurfacing course and understand that scar treatment has modest goals.
- People who want to ask specific questions about a product — what is in it, where the growth factors come from, at what concentration — and who want clear answers.
- People without an active skin condition, infection, or open lesion in the treatment area.
- People in generally good health, with any chronic condition well controlled, as assessed at a medical consultation.
This May Not Be Right For You If
- Anyone with an active infection, open wound, or inflammatory lesion in the treatment area, including active acne cysts or a herpes simplex outbreak, until it has resolved.
- Anyone with a known allergy or sensitivity to any component of the specific preparation being used. Ask for the full ingredient list if you have reactive skin or a history of contact allergy.
- Anyone with an active or recent malignancy, or a history of skin cancer at the site, without clearance from their treating physician. Growth factors are, by definition, signals that promote cell proliferation, and while a topical applied to skin is a very different situation from systemic exposure, the theoretical concern is raised in the literature and deserves a physician's judgment rather than an assumption.
- Anyone with an active inflammatory or autoimmune skin condition affecting the area, without input from the physician managing it.
- Anyone who is pregnant or breastfeeding, since elective aesthetic treatment is generally deferred and safety data in this context is absent.
- Anyone with a history of keloid or hypertrophic scarring, where the procedures this is paired with require caution in their own right.
- Anyone taking isotretinoin currently or recently, where the timing of any resurfacing or needling procedure needs to be discussed with the prescribing clinician.
- Anyone who objects to the source material of a particular formulation, which is a legitimate reason to decline and should be met with a straight answer about what that source is.
- Anyone expecting a topical product to deliver volume, lift, or a structural change. Nothing in this category does that.
Because topical cosmetic products are not subject to pre-market FDA approval for effectiveness, the useful consultation here is a specific one. Ask what product is being used, what growth factors it contains, how they are produced, at what concentration, and what evidence supports its use in the way it is being proposed. Ask whether it is being applied during a procedure, immediately after, or at home, since the timing determines how much reaches anywhere useful. A licensed provider should also review your medical history, ask about allergies and sensitivities, and be candid that this is an adjunct — a supporting element in a plan whose main work is done by the procedure it accompanies.
How PDGF (Ariessence) Compares
Growth-factor topicals are easy to confuse with the injectable regenerative treatments they share vocabulary with, and with the active topicals people already use at home. The table separates them.
| Feature | Topical PDGF | PRP (injected) | Prescription retinoid | Microneedling alone |
|---|---|---|---|---|
| What it is | A topical preparation containing growth-factor proteins | A concentrate of your own platelets, prepared from a blood draw | A topical vitamin A derivative prescribed for daily use | Controlled micro-injury from fine needles, with nothing added |
| How it is delivered | Applied to the skin, ideally while micro-channels are open | Injected into the dermis, or applied after needling | Applied at home on an ongoing routine | Performed in office as a procedure |
| Penetration | Poor through intact skin; depends on a procedure to open a route | Placed directly where it is intended to act | Small molecule that penetrates intact skin readily | Not applicable — the needles themselves reach depth |
| Primary role | Adjunct that supports a procedure already performed | Stand-alone regenerative treatment, often combined with needling | The best-evidenced topical for photoaging and texture | The stimulus that drives collagen remodeling |
| Evidence base | Manufacturer-led; formulations vary widely and are not comparable | Small studies with varied protocols; off-label for aesthetic use | Extensive, long-standing, and independent | Established for texture and atrophic scarring |
| US regulatory status | Generally marketed as a cosmetic — no pre-market approval for effectiveness | Off-label; not FDA-approved for aesthetic use | FDA-approved prescription medication | Specific devices are FDA-cleared for defined indications |
| Downtime of its own | None | Redness, swelling, and pinpoint bruising | Dryness, flaking, and irritation during adjustment | Redness, swelling, and flaking for several days |
These are not competitors so much as different layers of a plan, and the honest ordering matters: the procedure does most of the work, a prescription retinoid is the best-evidenced thing most people can do at home, and a growth-factor topical is a supporting element. A provider who presents an adjunct as the centerpiece is inverting that order, and it is reasonable to ask why.
What To Expect
Before The Treatment
- A consultation covering your skin, your goals, and the procedure this will accompany — since this is an add-on rather than a treatment scheduled on its own.
- A full medical history including allergies and sensitivities, current medications and topical products, any history of skin cancer or current malignancy, and any inflammatory or autoimmune skin condition.
- Specific questions answered about the product: what growth factors it contains, how they are produced, at what concentration, and what supports its use as proposed.
- A clear explanation of whether it will be applied during the procedure, immediately afterward, at home during recovery, or some combination — because the timing is what determines whether it reaches anywhere useful.
- Instructions on which of your usual products to stop beforehand, typically retinoids and exfoliating acids for a period before any needling or resurfacing.
- Instructions to arrive with clean skin, free of makeup, sunscreen, and topical products.
- A frank statement that this is an adjunct. If a topical is being presented as the main event, ask what evidence supports that framing.
Results: Onset And How Long It Lasts
Any change from a topical growth-factor preparation is gradual, modest, and difficult to separate from the effect of the procedure it accompanies — which is the honest position, and worth stating plainly. What patients typically describe over a course of treatment is improved surface texture, more even tone, and a better-hydrated appearance, developing across weeks to months rather than appearing after one session. It does not add volume, lift tissue, or change facial shape, and no formulation in this category does. Because this is an adjunct, the most useful way to think about the result is as a possible improvement on the outcome of the needling or resurfacing course it supports, rather than as a result of its own. Response varies between individuals and, importantly, between products, since formulations differ substantially in what they contain and at what concentration. This page publishes no numeric outcome figures: the evidence in this category is largely manufacturer-led, is not comparable between products, and averages drawn from it would tell you nothing reliable about your own skin. The effect is not permanent, and maintenance depends on continuing the underlying course of treatment.
During The Treatment
- The skin is cleansed and the accompanying procedure — usually microneedling or a resurfacing treatment — is performed as planned, with its own numbing and its own protocol.
- The growth-factor preparation is applied to the skin during or immediately after the procedure, while the micro-channels created are still open.
- Application itself is painless. Any discomfort during the appointment comes from the procedure it accompanies rather than from the topical.
- Some protocols include a period with the preparation left in contact with the skin, or repeated application across the treated area.
- You may be sent home with a supply and specific instructions on when to apply it during recovery, and that timing is part of the protocol rather than a suggestion.
- The appointment length is determined by the accompanying procedure; the topical step adds little to it.
- Afterward the skin will look flushed and feel warm and tight — that is the procedure, not the product.
How Often, And Why
Because this is an adjunct rather than a stand-alone procedure, its schedule follows whatever it accompanies. Where it is added to a microneedling course, it is applied at each session across that course — commonly a series spaced several weeks apart — and the cadence is set by the needling protocol rather than by the topical.
Some protocols include continued application at home during the recovery period after each session, and occasionally as ongoing maintenance between appointments. Whether that is worthwhile depends heavily on the specific formulation, since the penetration limitation that applies to intact skin applies just as much at home as it does in the clinic. It is a fair question to put directly to your provider: what is this doing when the channels have closed, and what supports that.
Maintenance, in this category, means maintaining the underlying course of treatment. The topical does not have an independent duration of effect to be sustained — it supports a remodeling process driven by the procedure, and when that course ends, the adjunct ends with it. Any longer-term plan should therefore be built around the procedure schedule and the home routine as a whole, with a prescription retinoid usually doing more of the work at home than any growth-factor preparation.
Afterward
- Follow the post-procedure instructions for the treatment this accompanied, which govern washing, product use, sun exposure, exercise, and makeup.
- Apply the growth-factor preparation only on the schedule you were given. During the period after needling, what goes on the skin reaches deeper than usual, and that cuts both ways.
- Do not resume your usual active skincare — retinoids, exfoliating acids, vitamin C, benzoyl peroxide, or scrubs — until your provider clears you. This matters more than people expect, and early resumption is a common cause of irritation.
- Avoid makeup for the interval specified, since micro-channels are a route for bacteria while they remain open.
- Avoid strenuous exercise, saunas, steam rooms, hot tubs, and swimming for the period you are given.
- Protect the treated skin from sun rigorously and use broad-spectrum sunscreen once you are cleared to apply products.
- Expect the visible recovery to be that of the accompanying procedure — redness, tightness, and some flaking as the surface turns over — rather than anything attributable to the topical.
- Report any new rash, spreading redness, itching beyond ordinary healing, or worsening irritation, which may indicate a reaction to a component of the preparation.
- Do not judge the result from a single appointment. Any effect from this category accrues across a course of treatment.
How Much Does PDGF (Ariessence) Cost in Atlanta, GA?
- What it is priced by: Per session
- Typical cost: From $999 / session
The figure above is a starting point, not a quote. What you pay depends on how much product your anatomy actually needs, which is a clinical judgement made in person. Ask at your consultation.
Side Effects And Downtime
Common And Expected
- Redness, warmth, and tightness in the treated area — attributable to the accompanying procedure rather than to the topical
- Mild stinging or tingling on application to freshly treated skin
- Dryness or fine flaking during recovery
- Temporary sensitivity to products and to sun
- Itching during healing
- Occasional mild irritation where a component of the formulation does not suit the skin
- Small blemishes or congestion in the days afterward, which can follow any occlusive product applied during recovery
When To Seek Care
- A spreading rash, marked itching, or swelling in or beyond the treated area, which may indicate an allergic reaction to a component of the preparation.
- Signs of an anaphylactic reaction — hives, swelling of the face, lips, tongue, or throat, wheezing, or difficulty breathing or swallowing. Call 911.
- Signs of infection: increasing rather than decreasing pain, spreading redness, warmth, swelling worsening after the first few days, pus or discharge, or fever.
- Severe or worsening pain out of proportion to what you were told to expect after the accompanying procedure.
- Any area that blisters, ulcerates, or fails to heal.
- A cold sore outbreak, which should be treated promptly to reduce the risk of scarring in freshly treated skin.
- Any new or changing lesion in the treated area, which should be assessed on its own merits rather than attributed to recent treatment.
Less Common, But Important To Know
- Allergic contact dermatitis or a hypersensitivity reaction to a component of the preparation — presenting as rash, spreading redness, marked itching, or swelling — which needs assessment rather than perseverance.
- Irritant contact dermatitis from application to skin that was not ready for it, or from resuming active skincare too early.
- Infection at the site, which relates to the accompanying procedure and to what was applied during the open-channel window rather than to the growth factors themselves. Increasing pain, spreading redness, warmth, pus, or fever warrant prompt attention.
- Reactivation of herpes simplex producing a cold sore, in anyone with a history of it, triggered by the accompanying procedure.
- Post-inflammatory hyperpigmentation — temporary darkening of treated skin — more likely in deeper skin tones and with inadequate sun protection.
- Granulomatous or delayed inflammatory reaction, which is uncommon but reported when foreign material is introduced through an opened skin barrier.
- Acneiform eruption or folliculitis following application of an occlusive preparation to freshly needled skin.
- Theoretical concern regarding growth factors and cell proliferation in anyone with an active malignancy or a skin cancer at the site. This is raised in the literature rather than demonstrated in this context, and it is why a physician's judgment is appropriate rather than an assumption.
- No discernible effect. Given the penetration constraints and the variability between formulations, this is a realistic outcome and an honest provider will not pretend otherwise.
Downtime
The topical itself adds no downtime. Everything you will experience in the days after the appointment belongs to the procedure it accompanies — the redness, tightness, warmth, and subsequent dryness and light flaking of microneedling or resurfacing, typically most pronounced in the first day or two and settling across the following several days. The practical constraints are the ones that come with that procedure: no makeup for the interval you are given, no active skincare until cleared, no strenuous exercise, saunas, steam, or swimming for the period specified, and rigorous sun protection afterward. The one thing this treatment adds to that list is a more specific instruction about what goes on your skin and when, because during the window when micro-channels remain open, anything applied reaches further than it usually would. Follow that schedule as given rather than improvising.
Who Performs This Treatment
Sharon Williams, NP-C
Aesthetic Injector, Nurse Practitioner · Injectables, neuromodulators, filler and facial balancingA bilingual (English/Spanish) nurse practitioner who came to aesthetics after more than a decade in medicine, including work as an RN across two hospitals, and earned her Master's degree in 2023. She describes her medical foundation as having shaped a thoughtful, safety-focused approach to injecting, centered on facial harmony and natural-looking results.
Helen Zhang, PA-C, MPAS
Co-Founder & Physician Assistant · Facial artistry, anatomy-driven injecting, facial balancing and harmonyA co-founder of the practice and a certified physician assistant whose interest in aesthetics crystallised during a plastic surgery rotation in PA school. With more than six years in aesthetic medicine she describes an anatomy-driven approach to facial artistry rooted in precision, restraint and long-term facial harmony, and calls herself the injector who tells you no.
PDGF (Ariessence) FAQs
No. This is a topical preparation applied to the skin, not injected. It is most often used as an add-on to microneedling or a resurfacing treatment, applied while the micro-channels created by the procedure are still open. It adds no needles, no injection points, and no bruising of its own to the appointment.
PRP is made from your own blood, prepared at the visit, and is injected into the skin or applied after needling. This is a manufactured topical preparation containing growth factors, applied to the surface. Both involve growth-factor signaling, but the source, the delivery, and the regulatory situation are all different — and PRP has no ingredient allergy consideration, while a topical formulation does.
Not meaningfully through intact skin, and this is the single most important thing to understand about the category. Growth factors are large proteins, and the outermost layer of skin is very effective at excluding molecules that size. That is precisely why this is paired with microneedling — the temporary micro-channels provide a route past the barrier for a limited window. Applied to undisturbed skin, considerably less gets anywhere useful.
Topical cosmetic products in the United States are not subject to pre-market FDA approval for effectiveness the way drugs are. A growth-factor topical is generally marketed as a cosmetic, which means claims about what it achieves rest on the manufacturer's own testing rather than on FDA review. That does not make it useless, but it does mean asking specific questions about the product is on you.
Some protocols include home application, particularly during recovery after a procedure. Whether it is worthwhile outside the open-channel window is a fair question to put to your provider directly, since the penetration limitation applies at home just as much as in the clinic. For most people, a prescription retinoid is the better-evidenced thing to be doing at home.
That varies by product, and it is worth asking specifically rather than assuming. Formulations in this category differ in what growth factors they contain, how those are produced, and at what concentration — which is why products are not interchangeable and why results reported for one do not transfer to another. A provider should be able to tell you plainly.
That is a question for your treating physician rather than for an aesthetic provider. Growth factors are by definition signals that promote cell proliferation, and while a topical applied to skin is a very different situation from systemic exposure, the theoretical concern is raised in the literature. An active malignancy, or a skin cancer at the treatment site, warrants clearance rather than an assumption.
Fine lines associated with declining dermal collagen are the plausible target, and improvement in surface texture and tone is what patients most commonly describe. Deeper static folds and lines caused by muscle movement are different problems requiring different treatments — a topical will not address either, regardless of formulation.
Not quickly, and it is genuinely difficult to separate any effect from that of the procedure it accompanies. Change in surface texture and tone develops across weeks to months and across a course of treatment rather than after a single session. Anyone describing a visible transformation from a topical growth-factor product is overstating the case.
Because the same micro-channels that let the growth-factor preparation reach a useful depth also let everything else in. During that window, an ordinary active — a retinoid, an acid, a vitamin C serum — reaches deeper than it was formulated to and is a common cause of irritation and reaction. The restriction is not fussiness, and the timeline you are given is worth following exactly.
An extra, and honest providers say so. The procedure it accompanies — microneedling or resurfacing — is what drives the remodeling. The topical is intended to support that. If a growth-factor product is being presented to you as the centerpiece of a plan, it is reasonable to ask what evidence supports that framing.
Elective aesthetic treatment is generally deferred during pregnancy and breastfeeding, and safety data for this category in that context is absent. That applies to the accompanying procedure as much as to the topical. Raise it at consultation, and expect the answer to be to wait.
Pairs Well With
Book Your Consultation
A consultation is a conversation about your face, not a sales appointment. Bring your questions about PDGF (Ariessence) and your medical history, and leave with an honest answer about whether it is the right treatment for you.
